Clincosm LogoSign in Get a demo

relapsed solid tumors

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSX01-TCRT injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSX01-TCRT injection
  • Nanning, Guangxi Zhuang Autonomous Region, China
    The first affiliated hospital of Guang Xi medical university
Mar 31, 2023

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSH01 injection
  • Nanning, Guang XI, China
    The first affiliated hospital of Guang Xi medical university
Sep 14, 2022

Relapsed Solid Tumors, Refractory Solid Tumors, Relapsed Leukemia Trial in Canada, United States (Carfilzomib, Cyclophosphamide,

Recruiting
  • Relapsed Solid Tumors
  • +3 more
  • Phoenix, Arizona
  • +7 more
Apr 12, 2022

Relapsed Solid Tumors, Refractory Solid Tumors Trial in Aurora, Lexington, Dallas (Eribulin, Irinotecan, Cefixime)

Completed
  • Relapsed Solid Tumors
  • Refractory Solid Tumors
  • Aurora, Colorado
  • +2 more
Jan 31, 2022

Pharmacokinetic Studies Participation Survey

Completed
  • Relapsed Solid Tumors
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 30, 2017